Peripheral CD8+ T Cells Predicts Immune-Related Adverse Events and Survival in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy

被引：0
|
作者：
Wu, K. [1 ]
Yang, S. [1 ]
Li, X. [1 ]
Xia, B. [1 ]
Ma, S. [1 ]
Chen, X. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hangzhou Canc Hosp, Hangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
immune-related adverse events; non-small cell lung cancer; Peripheral CD8+T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA09.03
引用
收藏
页码：S911 / S912
页数：2
相关论文
共 50 条
  • [31] Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab
    Bouhlel, Linda
    Doyen, Jerome
    Chamorey, Emmanuel
    Poudenx, Michel
    Ilie, Marius
    Gal, Jocelyn
    Guigay, Joel
    Benzaquen, Jonathan
    Marquette, Charles-Hugo
    Berthet, Jean-Philippe
    Mouroux, Jerome
    Schiappa, Renaud
    Padovani, Bernard
    Hofman, Paul
    Otto, Josiane
    BULLETIN DU CANCER, 2020, 107 (09) : 946 - 958
  • [32] Association Between Immune-Related Adverse Events and Survival in a Contemporary Metastatic Non-Small Cell Lung Cancer Cohort
    Cook, S.
    Samuel, V.
    Meyers, D.
    Stukalin, I.
    Litt, I.
    Sangha, R.
    Morris, D.
    Heng, D.
    Pabani, A.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S308
  • [33] Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?
    Remon, Jordi
    Reguart, Noemi
    Auclin, Edouard
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (06) : 963 - 967
  • [34] Blood cell gene expression and clinical characteristics in advanced non-small cell lung cancer with immune-related adverse events
    Daniello, L.
    Elshiaty, M.
    Lusky, F.
    Blasi, M.
    Schneider, M. A.
    Bozorgmehr, F.
    Shah, R.
    Kazdal, D.
    Angeles, A.
    Liersch, S.
    Eichhorn, F.
    Allgaeuer, M.
    Janke, F.
    Bischoff, H.
    Thomas, M.
    Sueltmann, H.
    Stenzinger, A.
    Christopoulos, P.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S79 - S79
  • [35] Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A real-world perspective.
    Rizwan, Saleha
    Alhamad, Khaled
    Abel, Stephen
    Bakalov, Veli
    Rodriguez, Robin Raquel
    Sethi, Ashish
    Khan, Talal
    Attah, Abraham Attah
    Yasir, Muhammad
    Shankar, Karthik
    Lo, Herman
    Friday, Andrew
    Finley, Gene Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer
    Hayashi, Hidetoshi
    Nishio, Makoto
    Akamatsu, Hiroaki
    Goto, Yasushi
    Miura, Satoru
    Gemma, Akihiko
    Yoshino, Ichiro
    Misumi, Toshihiro
    Kijima, Takashi
    Takase, Naoto
    Fujita, Masaki
    Tasaka, Sadatomo
    Mouri, Atsuto
    Kondo, Tetsuro
    Takamura, Kei
    Kawashima, Yosuke
    Imaizumi, Kazuyoshi
    Iwasawa, Shunichiro
    Nakagawa, Shintaro
    Mitsudomi, Tetsuya
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (11): : 2858 - 2867
  • [37] POTENTIAL ROLE OF SERUM PROTEOME IN PREDICTING IMMUNE-RELATED ADVERSE EVENTS FROM IMMUNOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Kim, Leeseul
    Chae, Young Kwang
    Lee, Dong-Uk
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A29 - A29
  • [38] Peripheral blood t cell responses to immunotherapy related adverse events in metastatic non-small cell lung cancer.
    Amara, Suneetha
    Muzaffar, Mahvish
    Namireddy, Praveen
    Yang, Li V.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events?
    Riondino, Silvia
    Rosenfeld, Roberto
    Formica, Vincenzo
    Morelli, Cristina
    Parisi, Giusy
    Torino, Francesco
    Mariotti, Sabrina
    Roselli, Mario
    CANCERS, 2024, 16 (07)
  • [40] Evaluation of immune-related adverse events in patients treated with sequential immunotherapy and tyrosine kinase inhibitor treatment in non-small cell lung cancer.
    Baroz, Angel Ray
    Mambetsariev, Isa
    Fricke, Jeremy
    Pharaon, Rebecca
    Zhao, Dan
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345